Insulin-independent Reversal of Type 1 Diabetes in Nonobese Diabetic Mice with Brown Adipose Tissue Transplant
Overview
Physiology
Authors
Affiliations
Traditional therapies for type 1 diabetes (T1D) involve insulin replacement or islet/pancreas transplantation and have numerous limitations. Our previous work demonstrated the ability of embryonic brown adipose tissue (BAT) transplants to establish normoglycemia without insulin in chemically induced models of insulin-deficient diabetes. The current study sought to extend the technique to an autoimmune-mediated T1D model and document the underlying mechanisms. In nonobese diabetic (NOD) mice, BAT transplants result in complete reversal of T1D associated with rapid and long-lasting euglycemia. In addition, BAT transplants placed prior to the onset of diabetes on NOD mice can prevent or significantly delay the onset of diabetes. As with streptozotocin (STZ)-diabetic models, euglycemia is independent of insulin and strongly correlates with decrease of inflammation and increase of adipokines. Plasma insulin-like growth factor-I (IGF-I) is the first hormone to increase following BAT transplants. Adipose tissue of transplant recipients consistently express IGF-I compared with little or no expression in controls, and plasma IGF-I levels show a direct negative correlation with glucose, glucagon, and inflammatory cytokines. Adipogenic and anti-inflammatory properties of IGF-I may stimulate regeneration of new healthy white adipose tissue, which in turn secretes hypoglycemic adipokines that substitute for insulin. IGF-I can also directly decrease blood glucose through activating insulin receptor. These data demonstrate the potential for insulin-independent reversal of autoimmune-induced T1D with BAT transplants and implicate IGF-I as a likely mediator in the resulting equilibrium.
Hemat Jouy S, Mohan S, Scichilone G, Mostafa A, Mahmoud A Biomedicines. 2024; 12(9).
PMID: 39335642 PMC: 11428859. DOI: 10.3390/biomedicines12092129.
The role of brown adipose tissue in mediating healthful longevity.
Zhang J, Kibret B, Vatner D, Vatner S J Cardiovasc Aging. 2024; 4(2).
PMID: 39119146 PMC: 11309368. DOI: 10.20517/jca.2024.01.
Thermogenic Fat as a New Obesity Management Tool: From Pharmaceutical Reagents to Cell Therapies.
Cheng Y, Liang S, Zhang S, Hui X Biomedicines. 2024; 12(7).
PMID: 39062047 PMC: 11275133. DOI: 10.3390/biomedicines12071474.
Dewal R, Yang F, Baer L, Vidal P, Hernandez-Saavedra D, Seculov N iScience. 2024; 27(2):108927.
PMID: 38327776 PMC: 10847743. DOI: 10.1016/j.isci.2024.108927.
Li J, He J, He H, Wang X, Zhang S, He Y Curr Res Food Sci. 2024; 8:100677.
PMID: 38303998 PMC: 10831159. DOI: 10.1016/j.crfs.2024.100677.